Chemoinformaics analysis of ethyl (E)-9-tetradecenoate
Molecular Weight | 254.414 | nRot | 12 |
Heavy Atom Molecular Weight | 224.174 | nRig | 2 |
Exact Molecular Weight | 254.225 | nRing | 0 |
Solubility: LogS | -6.009 | nHRing | 0 |
Solubility: LogP | 5.636 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 48.3278 |
nHD | 0 | BPOL | 32.7002 |
QED | 0.277 |
Synth | 2.021 |
Natural Product Likeliness | 0.716 |
NR-PPAR-gamma | 0.095 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.227 |
Pgp-sub | 0.002 |
HIA | 0.003 |
CACO-2 | -4.616 |
MDCK | 0.000031 |
BBB | 0.503 |
PPB | 0.987658 |
VDSS | 2.878 |
FU | 0.0114995 |
CYP1A2-inh | 0.941 |
CYP1A2-sub | 0.211 |
CYP2c19-inh | 0.67 |
CYP2c19-sub | 0.069 |
CYP2c9-inh | 0.587 |
CYP2c9-sub | 0.942 |
CYP2d6-inh | 0.426 |
CYP2d6-sub | 0.147 |
CYP3a4-inh | 0.574 |
CYP3a4-sub | 0.102 |
CL | 3.499 |
T12 | 0.711 |
hERG | 0.099 |
Ames | 0.002 |
ROA | 0.02 |
SkinSen | 0.952 |
Carcinogencity | 0.071 |
EI | 0.97 |
Respiratory | 0.629 |
NR-Aromatase | 0.059 |
Antiviral | Yes |
Prediction | 0.711475 |